ATC Group: A07DA01 Diphenoxylate

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A07DA01 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents
3 A07D Antipropulsives
4 A07DA Antipropulsives
5 A07DA01 Diphenoxylate

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 15 mg

Active ingredients in A07DA01

Active Ingredient Description

Diphenoxylate is a synthetic opioid derivative with selective effects on gastrointestinal smooth muscle. It is essentially devoid of “morphine type subjective effects” at therapeutic doses.

Related product monographs

Title Information Source Document Type  
LOMOTIL Tablet Health Products and Food Branch (CA) MPI, CA: SPM

Medicines in this ATC group

United States (US)

Australia (AU)

Canada (CA)

Ecuador (EC)

Hong Kong (HK)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.